Esta primeira versão de Medicamentos para prevenção da COVID-19: Orientação dinâmica da OMS aborda o uso de hidroxicloroquina para prevenção da COVID-19. Segue-se a publicação de uma análise sistemática e NMA que reuniu dados de seis estudos com 6.059 participantes que não tinham COVID-...19 e receberam hidroxicloroquina. Três estudos envolveram participantes que tiveram uma exposição conhecida a uma pessoa com infecção por SARS-CoV-2. Em resposta à divulgação dos dados de estudos, o GDG da OMS desenvolveu recomendações sobre a hidroxicloroquina, um agente anti-inflamatório que atua por meio do bloqueio dos receptores Toll-like, reduzindo a ativação das células dendríticas. É usada para tratar a artrite reumatoide e o lúpus eritematoso sistêmico. Tem um efeito antiviral contra muitos vírus in vitro, inclusive o SARS-CoV-2, mas não foi demonstrado um efeito antiviral clinicamente útil para nenhuma infecção viral.
more
This report highlights the increasing public health
burden of road traffic injuries and fatalities in
the Region. Road traffic deaths are becoming a
significant problem in Africa, rising at a faster rate
than in any other region. Fatalities increased by
nearly one fifth in the decade from 2010 ...to 2021,
with almost one quarter of a million people killed
on Africa’s roads within that decade
more
El Director General de la OMS, Dr. Tedros Adhanom Ghebreyesus, ha determinado que el recrudecimiento de la viruela símica (mpox) en la República Democrática del Congo y en un número creciente de países de África constituye una emergencia de salud pública de importancia internacional (ESPII) c...on arreglo al Reglamento Sanitario Internacional (2005) (RSI [2005]).
more
On 27 September 2024, the Ministry of Health of Rwanda confirmed the country’s first outbreak of Marburg virus disease (MVD), with health-care workers in Kigali particularly affected. While sporadic outbreaks have occurred in various parts of Africa since the first recognized cases in 1967, this o...utbreak is the third largest outbreak of MVD ever recorded to date. Marburg virus disease is a severe disease clinically similar to Ebola disease. With no approved treatments or vaccines for MVD, early intervention for those showing symptoms is crucial for improving survival rates.
more
What Children Should Know About Bilharzia; Educational Comic. ACKNOWLEDGEMENT: This document was made possible through a financial grant from Merck, Germany. In 2007, Merck entered into a partnership with the World Health Organization (WHO) to combat schistosomiasis in school children on the African... continent. In the medium term, Merck will donate 250 million tablets of Cesol 600 containing the active ingredient praziquantel. Merck will maintain its efforts until the disease has been eliminated in Africa.
more
Updated September 2021.
Provision of water and sanitation and good hygiene practices play an essential role in protecting human health during all disease outbreaks, including during Ebola Virus Disease (EVD) outbreaks. This question and answer document provides practical, evidence-based recommend...ations on minimum requirements and best practices for water, sanitation, hygiene (WASH). It was originally developed in 2014 during the West Africa Ebola Outbreak and has been updated in 2021 to reflect lessons learned and new operational research data. The key recommendations on WASH remain the same.
more
The West African Ebola outbreak has been the largest, most severe and most complex in human history. For more than a year, people from all over the world have answered the call to work with WHO to overcome this outbreak. Starting from the initial detection of the outbreak, to the arrival of the firs...t responders, to the overwhelming spread of cases in West Africa, to the moment when cases began to decline, ‘The Ebola Diaries’ is a series of first-person accounts describing what it has been like working on the front lines of a global health crisis of unprecedented proportions.
more
All personnel deployed by the World Health Organization (WHO) to any type of public health or humanitarian emergency need to have basic knowledge and skills to perform effectively and safely. That is why it is essential to be trained prior to deployment. GO training is a comprehensive package of mod...ular pre-deployment training materials for WHO staff, consultants and partners deployed for the Ebola outbreak response in West Africa. Each module is accompanied with a video lecture for self-learning purposes
more
WHO commissioned a survey, carried out in September/October 2015, among some 10 000 members of the public in 12 countries (2 per WHO Region: Barbados, China, Egypt, India, Indonesia, Mexico, Nigeria, the Russian Federation, Serbia, South Africa, Sudan and Viet Nam) on their use of antibiotics, knowl...edge of antibiotics and of antibiotic resistance. While not claiming to be exhaustive, this and other surveys will help WHO and partners to ensure efforts are focused on tackling some of the biggest gaps in understanding and the most prevalent misconceptions
more
O que as crianças devem saber sobre a esquistossomose - Banda desenhada
AGRADECIMENTO: Este documento foi produzido com o apoio financeiro da Merck Alemanha. Em 2007, a Merck estabeleceu uma parceria com a Organização Mundial da Saúde para combater a esquistossomose entre os estudantes no con...tinente africano. Inicialmente, a Merck fará uma doação de 250 milhões de comprimidos de Cesol 600, que contém o princípio ativo praziquantel. A Merck pretende dar continuidade a esse compromisso para que essa enfermidade seja eliminada na África.
more
معلومات ضرورية للأطفال
عن البلهارسيا
Bambo has bilharzia: what children should know about bilharzia. Comic book.
ACKNOWLEDGEMENT: This document was made possible through a financial grant from Merck, Germany. In 2007, Merck entered into a partnership with the World... Health Organization (WHO) to combat schistosomiasis in school children on the African continent. In the medium term, Merck will donate 250 million tablets of Cesol 600 containing the active ingredient praziquantel. Merck will maintain its efforts until the disease has been eliminated in Africa.
more
Nini watoto wanapaswa kujua kuhusu kichocho?
SHUKRANI: Maelezo haya yamewezekana kupitia msaada wa fedha kutoka kwa Merck KGaA, Ujerumani. katika mwaka 2007, Merck KGaA ilingia katika ushirikiano na Shirika la Afya Duniani (WHO) kupambana na kichocho kwa watoto wa shule katika bara la Afrika.Me...rck ina changia vidonge milioni 200 vyaa Cesol 600 zenye kiambatano imara cha praziquantel. Merk itaendeleza juhudi yake hadi hapo maradhi yatakapotokomezwa kabisa Africa.
more
Version 1.1. The WHO protocol has been adapted to resource-limited settings and builds on existing methodologies from the European Centre for Disease Prevention and Control (ECDC), the Global PPS project from University of Antwerp, the US Centers for Disease Control and Prevention (CDC), and the Med...icines Utilisation Research in Africa (MURIA).
Point Prevalence Surveys collects information on prescribing practices of antibiotics and other information relevant to treatment and management of infectious diseases in hospitalized patients, and complements surveillance of antimicrobial consumption.
more
Clinical management standard operating procedures.
Ebola virus disease (EVD) is a life-threatening multisystem illness associated with fever and gastrointestinal (GI) symptoms that frequently leads to hypovolaemia, metabolic acidosis, hypoglycaemia, and multi-organ failure. The prolonged 2013–201...6 EVD outbreak in West Africa allowed for an evolution of care such that by outbreak end many patients received individualized and optimized supportive care (oSoC), including volume resuscitation, symptom control, laboratory and bedside monitoring of glucose, electrolyte levels and organ dysfunction, as well as rapid detection and treatment of co-infections, potentially contributing to the downward trend in the case fatality rate (CFR).
This guidance should serve as a foundation for oSoC that should be followed to ensure both the best possible chance for survival and allow for reliable comparison of investigational therapeutic interventions as part of a randomized controlled trial. This guideline provides recommendations for the management of adults and children.
more
A total of 18 laboratories from 13 countries participated in the four rounds of EQA: 10 laboratories from eight African endemic countries, four of which participated in all four rounds and three in three rounds. The overall results showed that the median performance of these laboratories improved ov...er the four rounds. However, the proportion of laboratories reporting false–positive cases remains high and indicates a problem of specificity probably due to contamination. The proportion of laboratories reporting both false–positive and false–negative results raises the issue of the quality of the data reported by WHO in Africa as well as the results of the studies carried out in these different laboratories in various countries.
more
Available in 90 languages!
Parenting for Lifelong Health provides open-access online parenting resources during COVID-19. We are working with the World Health Organization, UNICEF, UNODC, the Global Partnership to End Violence Against Children, USAID, the Centers for Disease Control and Preventio...n, World Without Orphans, the World Childhood Foundation, the Internet of Good Things and Clowns Without Borders South Africa.
more
This implementation brief addresses integration of HIV testing services into family planning (FP) services. It is intended as a practical resource for national health programmes seeking to introduce or scale up HIV testing and linkage to HIV prevention, sexually transmitted infection, and antiretrov...iral therapy services in FP.
This document highlights emerging good practices and country experiences of integrated HIV prevention and testing services within FP and advocates for increased linkage for FP clients to HIV services according to their needs. It also brings together information on models of integration of HIV testing into FP services, programme examples from east and southern Africa and guidance on the implementation monitoring process.
more
Report of the WHO/Bill & Melinda Gates Foundation Consultation. The Consultation was organized back-to-back with the first annual meeting of the International Coordinating Group of the BMGF-funded project for human and dog rabies elimination in developing countries, held at WHO headquarters, Geneva,... Switzerland, from 5 to 7 October 2009. This allowed the Consultation to benefit from the participation of the national coordinators and advisers of the BMGF-funded projects in the Philippines, South Africa (KwaZulu-Natal) and the United Republic of Tanzania
more
Schistosomiasis is widely recognized as a disease that is socially determined. An understanding of the social and behavioural factors linked to disease transmission and control should play a vital role in designing policies and strategies for schistosomiasis prevention and control. To this must be a...dded the awareness that schistosomiasis is also a disease of poverty. It still survives in poverty-stricken, remote areas where there is little or no safe water or sanitation, and health care is scarce or non-existent. For a variety of complex reasons, many of which are addressed in this book, the disease is particularly prevalent in sub-Saharan Africa, and persists in certain areas of rural China. This concern for human behaviour in an environment of poverty echoes the concerns of the new research priority for “diseases of poverty” identified by the Special Programme for Research & Training in Tropical Diseases.
more
An interregional meeting on leishmaniasis among neighbouring endemic
countries in the Eastern Mediterranean, African and European regions was organized by the World Health Organization (WHO) Regional Office for the Eastern
Mediterranean in Amman, Jordan, from 23 to 25 September 2018. The meeting w...as attended by representatives from the health ministries of Albania, Georgia, Greece, Iran (Islamic Republic of), Iraq, Jordan, Lebanon, Morocco, Pakistan, Saudi Arabia, Sudan, Syrian Arab Republic and Tunisia. Representatives from Afghanistan, Algeria and Libya were unable to attend. The Secretariat comprised staff from WHO headquarters, WHO regional offices in the Eastern Mediterranean, Africa and Europe, WHO country offices in Iraq, Pakistan, Syrian Arab Republic and Yemen, and WHO temporary advisors from Spain and Tunisia.
more